News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lipitor, Atorvastatin Calcium Hydrate Greatly Inhibits Coronary Artery Plaque Progression: Yamanouchi Pharmaceutical Co., Ltd., Pfizer Japan


10/19/2005 5:12:35 PM

Tokyo (JCNN) - Yamanouchi Pharmaceutical (TSE: 4503) and Pfizer Japan jointly announced that the positive results of REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) trials on Lipitor, an atorvastatin calcium hydrate, were published in the January 6 issue of the New England Journal of Medicine (NEJM).

Read at JCN Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES